Mayne Pharma | Fremdkapital



Loan Capital Veränderung Datum
Ansell USD 706.6M 319.8M 2024-06
Avita Medical AUD 42.24M 1.25M 2024-12
Cochlear AUD 203.5M 1.4M 2024-12
CSL USD 9.33B 1.91B 2024-12
Healius AUD 1.22B 103M 2024-12
Integral Diagnostics AUD 341.63M 1.98M 2024-06
Medical Developments International AUD 1.76M 150K 2024-12
Nanosonics AUD 5.78M 385K 2024-12
Next Science USD 1.81M 1.24M 2024-12
Polynovo AUD 12.84M 857K 2024-06
Ramsay Health Care AUD 10.69B 359.3M 2024-12
ResMed USD 662.86M 4.72M 2024-12
Sigma Healthcare AUD 124.31M 2.53M 2024-07
Sonic Healthcare AUD 4.19B 333.39M 2024-12
Telix Pharmaceuticals AUD 551.82M 533.46M 2024-12



Mayne Pharma Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jun 2025.